TY  - JOUR

T1  - Feasibility and safety results from RAD-IO: a multi-stage trial of durvalumab (Medi4736) with chemoradiotherapy with 5-fluorouracil and mitomycin C in patients with muscle-invasive bladder cancer.

JO  - Journal of Clinical Oncology

UR  - https://eprints.whiterose.ac.uk/id/eprint/226193

PY  - 2025/02/18

AU  - James ND

AU  - van de Wiel J

AU  - Hughes A

AU  - Hodgkins A-M

AU  - Hafeez S

AU  - Zarkar A

AU  - De Santis M

AU  - Din OS

AU  - Mir R

AU  - Iddenden J

AU  - Bonner CV et al

ED  - 

DO  - DOI: 10.1200/jco.2025.43.5_suppl.778

VL  - 43

IS  - 5_suppl

SP  - 778

EP  - 778

Y2  - 2025/12/05

ER  -